| infections other than COVID-19 | |
| anti-inflammatoty and immuno-therapy | |
| Immunostimulants drugs | |
| convalescent plasma treatment | Hung IRC002 Study Team IRC005 Study Team INSIGHT FLU-IVIG ... |
| 4930 | Huijie Bian, 2020 | 2 | 31 | 3 | excluded | not a RCT | high risk of bias |
| 5612 | Bernaola, 2020 | 2 | 13 | 0 | excluded | not a RCT | risk of bias not avaialble |
| 8158 | Yildiz, 2021 | 2 | 1 | 0 | excluded | risk of bias not avaialble |
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
